✕
Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease
Jun 2, 2017289 viewsMesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication....
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523686/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523686/
Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect o
Like
Comment
Share
